These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34219611)

  • 1. The role of levosimendan in phosphine-induced cardiotoxicity: evaluation of electrocardiographic, echocardiographic, and biochemical parameters.
    Armandeh M; Bameri B; Baeeri M; Haghi-Aminjan H; Rahimifard M; Hassani S; Hooshangi Shayesteh MR; Khalid M; Samadi M; Hosseini R; Masoudi Fard M; Abdollahi M
    Toxicol Mech Methods; 2021 Nov; 31(9):631-643. PubMed ID: 34219611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic, hemodynamic, and biochemical evidence on the protective effects of exenatide against phosphine-induced cardiotoxicity in rat model.
    Bameri B; Armandeh M; Baeeri M; Haghi-Aminjan H; Rahimifard M; Hassani S; Hooshangi Shayesteh MR; Samadi M; Gholami M; Nayebpour M; Ostad SN; Abdollahi M
    Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S381-S396. PubMed ID: 34569344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The electrocardiographic, hemodynamic, echocardiographic, and biochemical evaluation of treatment with edaravone on acute cardiac toxicity of aluminum phosphide.
    Rahimi Kakavandi N; Asadi T; Hooshangi Shayesteh MR; Baeeri M; Rahimifard M; Baghaei A; Noruzi M; Sharifzadeh M; Abdollahi M
    Front Pharmacol; 2022; 13():1032941. PubMed ID: 36278198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and biochemical evidences on the protective effects of triiodothyronine against phosphine-induced cardiac and mitochondrial toxicity.
    Abdolghaffari AH; Baghaei A; Solgi R; Gooshe M; Baeeri M; Navaei-Nigjeh M; Hassani S; Jafari A; Rezayat SM; Dehpour AR; Mehr SE; Abdollahi M
    Life Sci; 2015 Oct; 139():30-9. PubMed ID: 26239436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the mechanisms of taurine in alleviating electrocardiographic, hemodynamic, and biochemical parameters following aluminum phosphide cardiotoxicity.
    Samadi M; Baeeri M; Haghi-Aminjan H; Rahimifard M; Gholami M; Hassani S; Sattari M; Azarmi Y; Bameri B; Armandeh M; Hooshangi Shayesteh MR; Eghbal MA; Abdollahi M
    Food Chem Toxicol; 2021 Aug; 154():112347. PubMed ID: 34139304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of minocycline in alleviating aluminum phosphide-induced cardiac hemodynamic and renal toxicity.
    Haghi-Aminjan H; Baeeri M; Rahimifard M; Alizadeh A; Hodjat M; Hassani S; Asghari MH; Abdollahi A; Didari T; Hosseini R; Sharifzadeh M; Abdollahi M
    Environ Toxicol Pharmacol; 2018 Dec; 64():26-40. PubMed ID: 30290328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the mechanisms of melatonin in protection of aluminum phosphide cardiotoxicity.
    Asghari MH; Moloudizargari M; Baeeri M; Baghaei A; Rahimifard M; Solgi R; Jafari A; Aminjan HH; Hassani S; Moghadamnia AA; Ostad SN; Abdollahi M
    Arch Toxicol; 2017 Sep; 91(9):3109-3120. PubMed ID: 28551710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of the hemodynamic and molecular features of phosphine, a potent mitochondrial toxicant in the heart, by cannabidiol.
    Hooshangi Shayesteh MR; Haghi-Aminjan H; Baeeri M; Rahimifard M; Hassani S; Gholami M; Momtaz S; Salami SA; Armandeh M; Bameri B; Samadi M; Mousavi T; Ostad SN; Abdollahi M
    Toxicol Mech Methods; 2022 May; 32(4):288-301. PubMed ID: 34711111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Levosimendan on Phosphine-Induced Nephrotoxicity: Biochemical and Histopathological Assessment.
    Baeeri M; Rahimifard M; Armandeh M; Bameri B; Khalid M; Haghi-Aminjan H; Farhadi R; Abdollahi M
    Drug Res (Stuttg); 2022 Feb; 72(2):109-118. PubMed ID: 34788887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological and molecular mechanisms of protection by iron sucrose against phosphine-induced cardiotoxicity: a time course study.
    Solgi R; Baghaei A; Golaghaei A; Hasani S; Baeeri M; Navaei M; Ostad SN; Hosseini R; Abdollahi M
    Toxicol Mech Methods; 2015; 25(4):249-57. PubMed ID: 25906050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats.
    Jafari A; Baghaei A; Solgi R; Baeeri M; Chamanara M; Hassani S; Gholami M; Ostad SN; Sharifzadeh M; Abdollahi M
    Food Chem Toxicol; 2015 Jun; 80():182-192. PubMed ID: 25796571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant potential of selegiline in treating acute toxicity of aluminium phosphide in rats.
    Maleki A; Hosseini MJ; Rahimi N; Abdollahi A; Akbarfakhrabadi A; Javadian N; Amiri S; Behnoush B; Dehpour AR
    Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):62-74. PubMed ID: 30712291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats.
    Azad A; Lall SB; Mittra S
    Acta Pharmacol Sin; 2001 Apr; 22(4):298-304. PubMed ID: 11742581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chrysin ameliorates aluminum phosphide-induced oxidative stress and mitochondrial damages in rat cardiomyocytes and isolated mitochondria.
    Khezri S; Sabzalipour T; Jahedsani A; Azizian S; Atashbar S; Salimi A
    Environ Toxicol; 2020 Oct; 35(10):1114-1124. PubMed ID: 32432806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levosimendan does not improve survival time in a rat model of verapamil toxicity.
    Abraham MK; Scott SB; Meltzer A; Barrueto F
    J Med Toxicol; 2009 Mar; 5(1):3-7. PubMed ID: 19191208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitriol attenuates the cytotoxicity induced by aluminium phosphide via inhibiting mitochondrial dysfunction and oxidative stress in rat isolated cardiomyocytes.
    Hafez AA; Samiei S; Salimi A; Jamali Z; Khezri S; Sheikhghaderi H
    Pestic Biochem Physiol; 2021 Jul; 176():104883. PubMed ID: 34119212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
    Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
    Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Echocardiographic Findings in Estimating Survival Probability of Intensive Care Unit Admitted Aluminum Phosphide Poisoned Patients.
    Elgazzar FM; Shama MA; Shoeib O; Hafez ASAF
    J Med Toxicol; 2022 Apr; 18(2):128-138. PubMed ID: 35083735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
    Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.
    Graudins A; Wong KK
    J Med Toxicol; 2010 Jun; 6(2):85-93. PubMed ID: 20473651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.